I Got Sick Spraying Pesticides on Weed. Now I Think All Farming Should Test Like Cannabis.
October 1, 2026
No Comments
What cannabis is teaching us about pesticides and modern agriculture.
High Times Contributors
Cannabis Costs $15 in One State and $52 in Another. Bourbon Doesn’t.
September 21, 2026
No Comments
An eighth costs $15 in Washington and $52 in Kentucky, where every buyer is a patient. Former Massachusetts cannabis regulator Shawn Collins uses High Times’ price index and a bourbon thought experiment to explain why state borders force every legal market to rebuild an entire supply chain, what license caps cost patients, and what’s holding the border shut.
Your Doctor Won’t Talk About Medical Cannabis? Here Are Five Questions That Change That.
September 21, 2026
No Comments
Many patients find their doctors go quiet when medical cannabis comes up. Dr. Joseph Rosado explains why, from gaps in medical training to legal caution and lingering stigma, what the evidence actually supports, and the five questions that can turn a doctor’s silence into an informed conversation about benefits, risks and interactions.
Garcia Hand Picked’s California Homecoming Put the Growers in the Room
July 6, 2026
No Comments
Garcia Hand Picked returned to California with a Berkeley gathering centered on legacy growers, guided tastings, photography, and live music.
Cannabis Doesn’t Have a Marketing Problem: The Pitch Has Been Amiss From The Start
May 22, 2026
No Comments
An MSO operator argues the industry spent a decade funding the wrong discipline. The customers were always there. The job was never persuasion, it was conversion.
Mexico’s Congress Has Had Four Years to Pass a Cannabis Law. 15,000 People Just Ran Out of Patience.
May 4, 2026
No Comments
15,000 people marched down Paseo de la Reforma on May 2nd demanding the cannabis law Mexico’s Congress has owed since 2021. A firsthand chronicle of a march that also had streets in Colombia and Chile.
The State of Indigenous Cannabis: Sovereignty, Healing, and the Future We’re Building Now
April 28, 2026
No Comments
Indigenous communities are redefining cannabis through sovereignty, healing, and policy—building a future the broader industry is only starting to recognize.
Matt Zorn and the Next Phase of America’s Drug Policy Revolution
April 27, 2026
No Comments
The renegade litigator who spent a decade suing federal drug agencies is now writing their policy from inside the building. What his trajectory tells us about how social movements actually succeed — and fail.
Cannabis Through the Ages: What Humanity Knew for Millennia — and What Prohibition Made Us Forget
April 21, 2026
No Comments
Cannabis has been used as medicine, ritual and creative fuel for over 10,000 years. A leading neuroscientist traces its full history — and makes the case that decades of prohibition didn’t just restrict a plant. It stalled science we’re still trying to catch up on.
Defense Wins Championships: Why Distribution (Not Branding) Will Determine Who Survives the Cannabis Shakeout
April 20, 2026
No Comments
69% of cannabis consumers have no brand preference. 18% say brand influences their purchase at all. So why is the industry still obsessed with logos and packaging? Eric Offenberger, CEO of Vext Science, argues the durable competitive moat in cannabis is the licensed retail door — not the brand on the package.
Legalization Was Supposed to Be Bad for Kids. It Turned Out to Be the Opposite
April 20, 2026
No Comments
Thirty years into the transition to regulated cannabis markets, teen use and ease of access are at or near the lowest levels ever recorded. It’s
This 4/20, Remember The Cannabis Prisoners Legalization Left Behind
April 20, 2026
No Comments
Stephanie Shepard writes that 4/20 should not only celebrate cannabis culture, but also confront the people still serving decades and life sentences for the same plant.
I Got Sick Spraying Pesticides on Weed. Now I Think All Farming Should Test Like Cannabis.
October 1, 2026
No Comments
What cannabis is teaching us about pesticides and modern agriculture.
Cannabis Costs $15 in One State and $52 in Another. Bourbon Doesn’t.
September 21, 2026
No Comments
An eighth costs $15 in Washington and $52 in Kentucky, where every buyer is a patient. Former Massachusetts cannabis regulator Shawn Collins uses High Times’ price index and a bourbon thought experiment to explain why state borders force every legal market to rebuild an entire supply chain, what license caps cost patients, and what’s holding the border shut.
Your Doctor Won’t Talk About Medical Cannabis? Here Are Five Questions That Change That.
September 21, 2026
No Comments
Many patients find their doctors go quiet when medical cannabis comes up. Dr. Joseph Rosado explains why, from gaps in medical training to legal caution and lingering stigma, what the evidence actually supports, and the five questions that can turn a doctor’s silence into an informed conversation about benefits, risks and interactions.
Garcia Hand Picked’s California Homecoming Put the Growers in the Room
July 6, 2026
No Comments
Garcia Hand Picked returned to California with a Berkeley gathering centered on legacy growers, guided tastings, photography, and live music.
Cannabis Doesn’t Have a Marketing Problem: The Pitch Has Been Amiss From The Start
May 22, 2026
No Comments
An MSO operator argues the industry spent a decade funding the wrong discipline. The customers were always there. The job was never persuasion, it was conversion.
Mexico’s Congress Has Had Four Years to Pass a Cannabis Law. 15,000 People Just Ran Out of Patience.
May 4, 2026
No Comments
15,000 people marched down Paseo de la Reforma on May 2nd demanding the cannabis law Mexico’s Congress has owed since 2021. A firsthand chronicle of a march that also had streets in Colombia and Chile.
The State of Indigenous Cannabis: Sovereignty, Healing, and the Future We’re Building Now
April 28, 2026
No Comments
Indigenous communities are redefining cannabis through sovereignty, healing, and policy—building a future the broader industry is only starting to recognize.
Matt Zorn and the Next Phase of America’s Drug Policy Revolution
April 27, 2026
No Comments
The renegade litigator who spent a decade suing federal drug agencies is now writing their policy from inside the building. What his trajectory tells us about how social movements actually succeed — and fail.
Cannabis Through the Ages: What Humanity Knew for Millennia — and What Prohibition Made Us Forget
April 21, 2026
No Comments
Cannabis has been used as medicine, ritual and creative fuel for over 10,000 years. A leading neuroscientist traces its full history — and makes the case that decades of prohibition didn’t just restrict a plant. It stalled science we’re still trying to catch up on.
Defense Wins Championships: Why Distribution (Not Branding) Will Determine Who Survives the Cannabis Shakeout
April 20, 2026
No Comments
69% of cannabis consumers have no brand preference. 18% say brand influences their purchase at all. So why is the industry still obsessed with logos and packaging? Eric Offenberger, CEO of Vext Science, argues the durable competitive moat in cannabis is the licensed retail door — not the brand on the package.
Legalization Was Supposed to Be Bad for Kids. It Turned Out to Be the Opposite
April 20, 2026
No Comments
Thirty years into the transition to regulated cannabis markets, teen use and ease of access are at or near the lowest levels ever recorded. It’s prohibition — not legalization — that put kids most at risk. This is an op-ed contribution from Adam J. Smith, Executive Director of the Marijuana Policy Project. The views expressed are his own. Legend has
This 4/20, Remember The Cannabis Prisoners Legalization Left Behind
April 20, 2026
No Comments
Stephanie Shepard writes that 4/20 should not only celebrate cannabis culture, but also confront the people still serving decades and life sentences for the same plant.
Subscribe to High Times
Get notified of our the latest cannabis news, exclusive brand deals, events updates and more!